arrow
N

Naamit K. Gerber

NYU Grossman School of Medicine
H指数:20
被引数:1,880

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and cross-validation of a novel multi-omic assay to assess locoregional recurrence risk and adjuvant therapy benefit in early-stage hormone receptor positive invasive breast cancer patients

开发并交叉验证一种新型多组学检测方法,以评估早期激素受体阳性浸润性乳腺癌患者的局部区域复发风险及辅助治疗获益。

2026-02-180
OAAI
Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report from the National Clinical Trials Network

将强度调制全身照射(IMRT-TBI)纳入未来合作组临床试验:国家临床试验网络中由NRG血液系统恶性肿瘤工作组主导的报告

2026-02-170
PRE
Curietherapy User eXperience pilot study (CurieUx): a feasibility study of a novel augmented reality educational tool during radiation oncology consultation for patients with breast cancer

近距离治疗用户体验试点研究(CurieUx):一项关于在乳腺癌患者放射肿瘤学咨询期间使用新型增强现实教育工具的可行性研究

2026-01-130
PRE
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors

I期b研究:达唑替尼加帕博利珠单抗在特定晚期实体瘤患者接受低分割放射治疗后的应用

2025-12-010
OA
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women with Low-Risk Ductal Carcinoma in Situ after Breast Conserving Surgery: The Impact of a 7-gene Biosignature based on 10-Year Ipsilateral Breast Recurrence (IBR) Rates

仅依靠临床病理因素预测行保乳术后低风险导管原位癌女性放疗获益的应用局限性:基于10年同侧乳腺复发(IBR)率的7基因生物标志物的影响

2025-07-180
PREAI
ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study
2024-07-150
OA
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study

保乳手术后导管原位癌患者放射治疗决策的7基因生物签名的临床效用: dcision rt的最新分析®预测研究

2024-06-258
OAAI
Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline
2024-03-0163
OAAI